RecruitingPhase 3NCT05120076

Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy

Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy- a Double-blinded Placebo Controlled RCT


Sponsor

Balgrist University Hospital

Enrollment

60 participants

Start Date

Jul 16, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to assess the effect of Dexamethasone on postoperative pain and nausea after periacetabular osteotomy.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexamethasone 4 Mg/mL Injectable Solution and a drug called NaCl 0.9% for people with amount of postoperative opioid use in milligrams, pain, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexamethasone 4 Mg/mL Injectable Solution

s. arm/group description

DRUGNaCl 0.9%

s. arm/group description


Locations(1)

Uniklinik Balgrist

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05120076


Related Trials